These novel therapies, including Wegovy, a similar compound, and Zaxig , represent a significant advancement in managing type 2 hyperglycemia and supporting weight management. They function by imitating the body’s natural incretin GLP-1 , enabling to regulate blood glucose and reduce cravings. Each medication has slightly distinct properties and